Discussions: Our results provide additional support for the role of inflammation in colon cancer and indicate that IL-8 could be further validated in association with other already used markers for prognostic and diagnostic of evolutional disease in colon cancer patients. This evidence concerns the gene CXCL8 and colonic neoplasm.